Skip Navigation

Japanese Journal of Clinical Oncology 2005 35(5):287-288; doi:10.1093/jjco/hyi083
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Asamura, H.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Asamura, H.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?


© 2005 Foundation for Promotion of Cancer Research

Multipoint Oncology Teleconference, Japan

Multipoint Oncology Teleconference, Japan

H. Asamura

The first 10% of the full text of this article appears below.

This teleconference has been held on a weekly basis (on Thursday evenings) as a good opportunity for the discussion of important issues in clinical oncology. Nowadays, this plenary meeting among the major cancer centers is indispensable for maintaining the high standard of quality of cancer clinics throughout Japan.

Review (March 2005 series)

March 3: Metastatic breast cancer and treatment with Herceptin (moderated by Dr Yamamoto, Chiba Cancer Center Chiba). More than 3 years have . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?